AIRSUPRA 90 ug/1 (Albuterol sulfate and budesonide AEROSOL, METERED) 90 ug/1

AIRSUPRA 90 ug/1 combines albuterol sulfate and budesonide for respiratory conditions. This metered aerosol inhaler offers dual-action relief for asthma and COPD management.

Strength

90 ug/1

Pack Size

1 INHALER in 1 CARTON (0310-9080-12) / 120 AEROSOL, METERED in 1 INHALER

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AIRSUPRA 90 ug/1 is primarily used for the maintenance and prevention of asthma and chronic obstructive pulmonary disease (COPD). The combination of albuterol sulfate and budesonide works to open airways and reduce inflammation. This inhaler is often prescribed for long-term management of respiratory conditions where both bronchodilation and anti-inflammatory effects are beneficial.

Side Effects

Common effects of AIRSUPRA 90 ug/1 may include improved breathing and reduced wheezing due to its bronchodilator and anti-inflammatory properties. Some users may experience mild side effects such as throat irritation or a slight increase in heart rate.

Precautions & Warnings

AIRSUPRA 90 ug/1 should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Patients should be aware of potential side effects and consult their healthcare provider if they experience any adverse reactions.

Avoid Interactions

AIRSUPRA 90 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this inhaler.

Frequently Asked Questions

AIRSUPRA 90 ug/1 is used for the maintenance and prevention of asthma and COPD. It combines albuterol sulfate and budesonide to provide bronchodilation and anti-inflammatory effects.

AIRSUPRA 90 ug/1 should be administered via inhalation, following the instructions provided by your healthcare provider. It is important to use the inhaler correctly to ensure effective delivery of the medication.

Common side effects may include throat irritation and a slight increase in heart rate. If you experience severe or persistent side effects, consult your healthcare provider.

AIRSUPRA 90 ug/1 may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

AIRSUPRA 90 ug/1 is often prescribed for long-term management of respiratory conditions. However, the duration of use should be determined by your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.